P. Pasanen

发表

Multivariate analysis of six serum tumor markers (CEA, CA 50, CA 242, TPA, TPS, TATI) and conventional laboratory tests in the diagnosis of hepatopancreatobiliary malignancy.

K. Partanen, M. Eskelinen, E. Alhava, 1995, Anticancer research.

Tumour-associated trypsin inhibitor in the diagnosis of pancreatic carcinoma

K. Partanen, M. Eskelinen, E. Alhava, 2005, Journal of Cancer Research and Clinical Oncology.

A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score.

K. Partanen, M. Eskelinen, E. Alhava, 1994, British Journal of Cancer.

Value of serum alkaline phosphatase, aminotransferases, gamma-glutamyl transferase, leucine aminopeptidase, and bilirubin in the distinction between benign and malignant diseases causing jaundice and cholestasis: results from a prospective study.

K. Partanen, E. Alhava, I. Penttilä, 1993, Scandinavian journal of clinical and laboratory investigation.

Tumour-associated trypsin inhibitor (TATI) in patients with colorectal cancer: a comparison with CEA, CA 50 and CA 242.

M. Eskelinen, E. Alhava, I. Penttilä, 1995, Scandinavian journal of clinical and laboratory investigation.

Diagnostic accuracy of ultrasound, computed tomography and endoscopic retrograde cholangiopancreatography in the detection of pancreatic cancer in patients with jaundice or cholestasis.

K. Partanen, E. Alhava, P. Pasanen, 1992, In vivo.

Clinical evaluation of serum tumour markers CEA, CA 50 and CA 242 in colorectal cancer.

M. Pääkkönen, E. Alhava, P. Miettinen, 1994, Anticancer research.

Clinical value of serum tumour markers CEA, CA 50 and CA 242 in the distinction between malignant versus benign diseases causing jaundice and cholestasis; results from a prospective study.

K. Partanen, M. Eskelinen, E. Alhava, 1992, Anticancer research.

Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective study.

K. Partanen, M. Eskelinen, E. Alhava, 1993, British Journal of Cancer.

A prospective study of the value of imaging, serum markers and their combination in the diagnosis of pancreatic carcinoma in symptomatic patients.

K. Partanen, M. Eskelinen, E. Alhava, 1992, Anticancer research.

The outcome of elderly patients after operation for acute abdomen.

E. Alhava, P. Miettinen, P. Pasanen, 1996, Annales chirurgiae et gynaecologiae.

Argyrophilic nucleolar organizer regions may help the differential diagnostic distinction between chronic pancreatitis and pancreatic ductal adenocarcinoma.

P. Lipponen, M. Eskelinen, E. Alhava, 1994, Scandinavian journal of gastroenterology.

Ultrasonography, CT, and ERCP in the Diagnosis of Choledochal Stones

P Pikkarainen, K. Partanen, E. Alhava, 1992, Acta radiologica.

Acute abdominal pain in adults.

E. Alhava, P. Miettinen, P. Pasanen, 1996, Annales chirurgiae et gynaecologiae.

Paraesophageal bronchogenic cyst in the adult: can it be differentiated from intramural esophageal cyst by different imagings? Case report and review of the literature.

P. Pasanen, K. Partanen, X. Yang, 1994, Clinical imaging.

Diagnostic accuracy of ultrasound, computed tomography, and endoscopic retrograde cholangiopancreatography in the detection of obstructive jaundice.

K. Partanen, E. Alhava, P. Pasanen, 1991, Scandinavian journal of gastroenterology.

Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma.

K. Partanen, M. Eskelinen, E. Alhava, 1992, British Journal of Cancer.

Nuclear magnetic resonance spectroscopy of plasma to distinguish between malignant and benign diseases causing jaundice and cholestasis

R. Kauppinen, K. Partanen, M. Eskelinen, 2005, Journal of Cancer Research and Clinical Oncology.

A comparison of ultrasound, computed tomography and endoscopic retrograde cholangiopancreatography in the differential diagnosis of benign and malignant jaundice and cholestasis.

K. Partanen, E. Alhava, P. Pasanen, 1993, The European journal of surgery = Acta chirurgica.

Analysis of the risk factors and their combinations in acute gastroduodenal ulcer bleeding: A case-control study

P. Miettinen, H. Mustonen, M. Udd, 2007, Scandinavian journal of gastroenterology.

Evaluation of a computer-based diagnostic score system in the diagnosis of jaundice and cholestasis.

K. Partanen, E. Alhava, P. Pasanen, 1993, Scandinavian journal of gastroenterology.

Ultrasonography and Computed Tomography in Diffuse Liver Disease with Cholestasis

K. Partanen, S. Soimakallio, E. Alhava, 1990, Acta radiologica.

Primary malignant schwannoma of the small bowel.

V. Kosma, M. Eskelinen, E. Alhava, 1992, Annales chirurgiae et gynaecologiae.

Diagnostic value of tissue polypeptide specific antigen in patients with pancreatic carcinoma.

M. Eskelinen, E. Alhava, I. Penttilä, 1994, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Clinical evaluation of tissue polypeptide antigen (TPA) in the diagnosis of pancreatic carcinoma.

K. Partanen, M. Eskelinen, P. Pasanen, 1993, Anticancer research.

The long-term outcome after negative appendix operation.

E. Alhava, P. Kosonen, P. Miettinen, 1995, Annales chirurgiae et gynaecologiae.

Small intestinal mucin antigen (SIMA); a novel tumour marker in colorectal cancer?

E. Alhava, P. Pasanen, A. Linnane, 1995, Anticancer Research.